Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1051
mi
from
Durham, NC
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1051
mi
from
Durham, NC
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
810
mi
from
Columbus, OH
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1383
mi
from
Portland, OR
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
983
mi
from
Erie, PA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
983
mi
from
Erie, PA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1147
mi
from
Hershey, PA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1147
mi
from
Hershey, PA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1225
mi
from
Philadelphia, PA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
618
mi
from
Nashville, TN
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
618
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
522
mi
from
Austin, TX
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
522
mi
from
Austin, TX
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
349
mi
from
Dallas, TX
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
398
mi
from
Tyler, TX
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
398
mi
from
Tyler, TX
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1053
mi
from
Charlottesville, VA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1410
mi
from
Seattle, WA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
1407
mi
from
Tacoma, WA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
1407
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Clinical Research Facility
196
mi
from
Kansas City, KA
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Clinical Research Facility
196
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated:  12/3/2015
Investigational Site Number 056010
4705
mi
from
Aalst,
A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation
Status: Enrolling
Updated: 12/3/2015
Investigational Site Number 056010
4705
mi
from
Aalst,
Click here to add this to my saved trials
Management of New-Onset Postoperative Atrial Fibrillation
Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF
Status: Enrolling
Updated:  12/10/2015
Emory University Hospital Midtown
801
mi
from
Atlanta, GA
Management of New-Onset Postoperative Atrial Fibrillation
Management of New-Onset Postoperative Atrial Fibrillation Utilizing Insertable Cardiac Monitor Technology to Observe Recurrence of AF
Status: Enrolling
Updated: 12/10/2015
Emory University Hospital Midtown
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
1127
mi
from
Washington,
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
1127
mi
from
Washington,
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
1312
mi
from
Hollywood, FL
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
1312
mi
from
Hollywood, FL
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
1055
mi
from
Jacksonville, FL
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
1142
mi
from
Sarasota, FL
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
1142
mi
from
Sarasota, FL
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
725
mi
from
Lexington, KY
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
725
mi
from
Lexington, KY
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
697
mi
from
New Orleans, LA
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
1193
mi
from
Johnson City, NY
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
1193
mi
from
Johnson City, NY
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
599
mi
from
Germantown, TN
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
599
mi
from
Germantown, TN
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
569
mi
from
Houston, TX
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
569
mi
from
Houston, TX
Click here to add this to my saved trials
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated:  12/11/2015
Otsuka Investigational Site
mi
from
Berlin,
Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
A Multi-center, Parallel-group, Double-blind, Placebo-controlled, Randomized, Ascending Dose Trial to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Infusions of OPC-108459 Administered to Subjects With Paroxysmal and Persistent Atrial Fibrillation
Status: Enrolling
Updated: 12/11/2015
Otsuka Investigational Site
mi
from
Berlin,
Click here to add this to my saved trials
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism in Patients Undergoing Left Atrial Catheter Ablation Procedures for Paroxysmal or Persistent (Non-permanent) Atrial Fibrillation and Left Atrial Flutter
Status: Enrolling
Updated:  12/11/2015
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism in Patients Undergoing Left Atrial Catheter Ablation Procedures for Paroxysmal or Persistent (Non-permanent) Atrial Fibrillation and Left Atrial Flutter
Status: Enrolling
Updated: 12/11/2015
Vanderbilt University Medical Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Randomized Trial of Interventions to Improve Warfarin Adherence
Randomized Trial of Interventions to Improve Warfarin Adherence
Status: Enrolling
Updated:  12/15/2015
Hospital of the University of Pennsylvania Anticoagulation Management Center
1223
mi
from
Philadelphia, PA
Randomized Trial of Interventions to Improve Warfarin Adherence
Randomized Trial of Interventions to Improve Warfarin Adherence
Status: Enrolling
Updated: 12/15/2015
Hospital of the University of Pennsylvania Anticoagulation Management Center
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Randomized Trial of Interventions to Improve Warfarin Adherence
Randomized Trial of Interventions to Improve Warfarin Adherence
Status: Enrolling
Updated:  12/15/2015
Philadelphia Veteran Affairs Medical Center
1223
mi
from
Philadelphia, PA
Randomized Trial of Interventions to Improve Warfarin Adherence
Randomized Trial of Interventions to Improve Warfarin Adherence
Status: Enrolling
Updated: 12/15/2015
Philadelphia Veteran Affairs Medical Center
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Medtronic Reveal XT Study
A Comparison of Traditional Arrhythmia Assessment With the Use of Continuous Monitoring to Quantify Postoperative Arrhythmia Burden Following Surgical Treatment of Atrial Fibrillation- Medtronic Reveal XT Study
Status: Enrolling
Updated:  12/15/2015
Northwestern University
611
mi
from
Chicago, IL
Medtronic Reveal XT Study
A Comparison of Traditional Arrhythmia Assessment With the Use of Continuous Monitoring to Quantify Postoperative Arrhythmia Burden Following Surgical Treatment of Atrial Fibrillation- Medtronic Reveal XT Study
Status: Enrolling
Updated: 12/15/2015
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Medtronic Reveal XT Study
A Comparison of Traditional Arrhythmia Assessment With the Use of Continuous Monitoring to Quantify Postoperative Arrhythmia Burden Following Surgical Treatment of Atrial Fibrillation- Medtronic Reveal XT Study
Status: Enrolling
Updated:  12/15/2015
Washington University School of Medicine
415
mi
from
St. Louis, MO
Medtronic Reveal XT Study
A Comparison of Traditional Arrhythmia Assessment With the Use of Continuous Monitoring to Quantify Postoperative Arrhythmia Burden Following Surgical Treatment of Atrial Fibrillation- Medtronic Reveal XT Study
Status: Enrolling
Updated: 12/15/2015
Washington University School of Medicine
415
mi
from
St. Louis, MO
Click here to add this to my saved trials
PREdicting Atrial Fibrillation or Flutter
PREdicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF)"
Status: Enrolling
Updated:  1/1/2016
Keesler Medical Center
718
mi
from
Keesler AFB, MS
PREdicting Atrial Fibrillation or Flutter
PREdicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF)"
Status: Enrolling
Updated: 1/1/2016
Keesler Medical Center
718
mi
from
Keesler AFB, MS
Click here to add this to my saved trials
The Genetic Basis of Atrial Fibrillation (AF)
The Genetic Basis of Atrial Fibrillation
Status: Enrolling
Updated:  1/4/2016
University of Pittsburgh Medical Center/Comprehensive Heart Ctr.
974
mi
from
Pittsburgh, PA
The Genetic Basis of Atrial Fibrillation (AF)
The Genetic Basis of Atrial Fibrillation
Status: Enrolling
Updated: 1/4/2016
University of Pittsburgh Medical Center/Comprehensive Heart Ctr.
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated:  1/4/2016
Stanford Univ Med Ctr
1329
mi
from
Stanford, CA
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated: 1/4/2016
Stanford Univ Med Ctr
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated:  1/4/2016
Colorado Springs Cardiology/Colorado Cardiac Alliance
386
mi
from
Colorado Springs, CO
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated: 1/4/2016
Colorado Springs Cardiology/Colorado Cardiac Alliance
386
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated:  1/4/2016
Vanderbilt Heart Institute
618
mi
from
Nashville, TN
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated: 1/4/2016
Vanderbilt Heart Institute
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated:  1/4/2016
Sentara Norfolk Hospital
1182
mi
from
Norfolk, VA
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated: 1/4/2016
Sentara Norfolk Hospital
1182
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated:  1/4/2016
Universitair Ziekenhuis Brussel
4719
mi
from
Brussel,
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Status: Enrolling
Updated: 1/4/2016
Universitair Ziekenhuis Brussel
4719
mi
from
Brussel,
Click here to add this to my saved trials
Effects of Left Atrial Appendage Occlusion
Effects of Left Atrial Appendage Occlusion
Status: Enrolling
Updated:  1/4/2016
University of Pittsburgh Medical Center/Comprehensive Heart Ctr.
974
mi
from
Pittsburgh, PA
Effects of Left Atrial Appendage Occlusion
Effects of Left Atrial Appendage Occlusion
Status: Enrolling
Updated: 1/4/2016
University of Pittsburgh Medical Center/Comprehensive Heart Ctr.
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
Status: Enrolling
Updated:  1/4/2016
UPMC CVI
974
mi
from
Pittsburgh, PA
Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
Status: Enrolling
Updated: 1/4/2016
UPMC CVI
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)
Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)
Status: Enrolling
Updated:  1/4/2016
UPMC Cardiovascular Institute
971
mi
from
Pittsburgh, PA
Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)
Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)
Status: Enrolling
Updated: 1/4/2016
UPMC Cardiovascular Institute
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol
Status: Enrolling
Updated:  1/5/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Continued Access Protocol
Status: Enrolling
Updated: 1/5/2016
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Scripps Memorial/ Kaiser Permanente
1152
mi
from
La Jolla, CA
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Scripps Memorial/ Kaiser Permanente
1152
mi
from
La Jolla, CA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Long Beach Memorial Medical Center
1171
mi
from
Long Beach, CA
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Long Beach Memorial Medical Center
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Kaiser Permanente Los Angeles Medical Center
1169
mi
from
Los Angeles, CA
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Kaiser Permanente Los Angeles Medical Center
1169
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Mercy General Hospital
1280
mi
from
Sacramento, CA
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Mercy General Hospital
1280
mi
from
Sacramento, CA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Piedmont Hospital
800
mi
from
Atlanta, GA
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Piedmont Hospital
800
mi
from
Atlanta, GA
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Methodist Hospital
643
mi
from
Indianapolis, IN
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Methodist Hospital
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
St. Francis Hospital and Health Center
646
mi
from
Indianapolis, IN
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
St. Francis Hospital and Health Center
646
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated:  1/5/2016
Alegent Health
258
mi
from
Omaha, NE
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
Status: Enrolling
Updated: 1/5/2016
Alegent Health
258
mi
from
Omaha, NE
Click here to add this to my saved trials